Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Services (HCSG) Payables (2016 - 2025)

Historic Payables for Healthcare Services (HCSG) over the last 17 years, with Q4 2025 value amounting to $77.4 million.

  • Healthcare Services' Payables fell 463.97% to $77.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $77.4 million, marking a year-over-year decrease of 463.97%. This contributed to the annual value of $77.4 million for FY2025, which is 463.97% down from last year.
  • According to the latest figures from Q4 2025, Healthcare Services' Payables is $77.4 million, which was down 463.97% from $81.7 million recorded in Q3 2025.
  • Healthcare Services' 5-year Payables high stood at $83.2 million for Q4 2023, and its period low was $47.8 million during Q1 2021.
  • Over the past 5 years, Healthcare Services' median Payables value was $69.4 million (recorded in 2022), while the average stood at $69.1 million.
  • Its Payables has fluctuated over the past 5 years, first tumbled by 2144.95% in 2021, then skyrocketed by 3409.77% in 2022.
  • Healthcare Services' Payables (Quarter) stood at $64.4 million in 2021, then increased by 6.02% to $68.3 million in 2022, then rose by 21.86% to $83.2 million in 2023, then dropped by 2.5% to $81.1 million in 2024, then fell by 4.64% to $77.4 million in 2025.
  • Its Payables stands at $77.4 million for Q4 2025, versus $81.7 million for Q3 2025 and $77.9 million for Q2 2025.